News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,572 Results
Type
Article (14196)
Company Profile (282)
Press Release (252094)
Section
Business (79526)
Career Advice (153)
Deals (13230)
Drug Delivery (35)
Drug Development (50445)
Employer Resources (31)
FDA (5716)
Job Trends (5128)
News (144417)
Policy (10033)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (911)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21637)
ALS (60)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (86)
Approvals (5731)
Artificial intelligence (108)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4561)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (139)
Cancer (1288)
Cardiovascular disease (105)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (305)
Cervical cancer (8)
Clinical research (40875)
Collaboration (497)
Compensation (218)
Complete response letters (13)
COVID-19 (1034)
CRISPR (36)
C-suite (141)
Cystic fibrosis (76)
Data (1346)
Denatured (11)
Depression (28)
Diabetes (125)
Diagnostics (1292)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (81)
Earnings (29639)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48124)
Executive appointments (396)
FDA (6333)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (464)
Gene editing (87)
Generative AI (9)
Gene therapy (228)
GLP-1 (353)
Government (1075)
Grass and pollen (2)
Guidances (18)
Healthcare (6589)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (79)
Indications (18)
Infectious disease (1096)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (55)
Interviews (17)
IPO (7262)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (200)
Leadership (2)
Legal (1388)
Liver cancer (30)
Lung cancer (185)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (115)
MASH (48)
Medical device (2590)
Medtech (2591)
Mergers & acquisitions (6254)
Metabolic disorders (363)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1189)
NextGen: Class of 2025 (2022)
Non-profit (852)
Northern California (1535)
Now hiring (21)
Obesity (185)
Opinion (100)
Ovarian cancer (60)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (104)
Partnered (8)
Patents (109)
Patient recruitment (66)
Peanut (35)
People (25504)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14428)
Phase II (19017)
Phase III (12026)
Pipeline (688)
Podcasts (46)
Policy (36)
Postmarket research (852)
Preclinical (6060)
Press Release (30)
Prostate cancer (53)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (272)
Real estate (1416)
Recruiting (12)
Regulatory (8557)
Reports (15)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (3)
RSV (10)
Schizophrenia (56)
Series A (91)
Series B (60)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1360)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1973)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (12006)
Vaccines (205)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (61)
Last 7 days (388)
Last 30 days (1505)
Last 365 days (20001)
2025 (4621)
2024 (20556)
2023 (22416)
2022 (26825)
2021 (27808)
2020 (23362)
2019 (16230)
2018 (11741)
2017 (13749)
2016 (11846)
2015 (14360)
2014 (10415)
2013 (7498)
2012 (7538)
2011 (7622)
2010 (7431)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17219)
Australia (2915)
California (3490)
Canada (1046)
China (321)
Colorado (135)
Connecticut (143)
Delaware (87)
Europe (37023)
Florida (408)
Georgia (106)
Idaho (16)
Illinois (209)
India (8)
Indiana (85)
Iowa (1)
Japan (69)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (442)
Massachusetts (2746)
Michigan (69)
Minnesota (134)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (874)
New Mexico (12)
New York (950)
North Carolina (517)
North Dakota (4)
Northern California (1535)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (669)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1360)
Tennessee (25)
Texas (400)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (317)
Wisconsin (13)
266,572 Results for "heron therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates
February 27, 2025
·
15 min read
Press Releases
Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025
February 14, 2025
·
2 min read
Press Releases
Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina
December 24, 2024
·
2 min read
Business
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced financial results for the three months ended March 31, 2024 and highlighted recent corporate updates.
May 7, 2024
·
15 min read
Press Releases
Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors
November 4, 2024
·
2 min read
Policy
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle (“VAN”)
Heron Therapeutics, Inc., a commercial-stage biotechnology company, announced the Prior Approval Supplement submission to the U.S. Food and Drug Administration for ZYNRELEF® extended-release solution Vial Access Needle.
May 29, 2024
·
7 min read
Biotech Bay
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate in a fireside chat on Wednesday, April 10, 2024, at 11:00 AM ET at the 23rd Annual Needham Virtual Healthcare Conference.
March 28, 2024
·
1 min read
Press Releases
Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
November 13, 2024
·
16 min read
Biotech Beach
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Heron Therapeutics, Inc., a commercial-stage biotechnology company, announced that it will host an Investor Day on Wednesday, May 15, 2024 in New York City, beginning at 9:30 am ET.
April 11, 2024
·
2 min read
Business
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Heron Therapeutics, Inc. today announced that the company will host a conference call and live webcast on Tuesday, May 7, 2024, at 8:30 a.m. ET to report first quarter 2024 financial results and discuss recent business highlights.
April 24, 2024
·
2 min read
1 of 26,658
Next
